- Home
- GNL vs HRMY Comparison
GNL vs HRMY Comparison
Compare GNL & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNL
- HRMY
- Stock Information
- Founded
- GNL 2011
- HRMY 2017
- Country
- GNL United States
- HRMY United States
- Employees
- GNL N/A
- HRMY N/A
- Industry
- GNL Real Estate Investment Trusts
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- GNL Real Estate
- HRMY Health Care
- Exchange
- GNL Nasdaq
- HRMY Nasdaq
- Market Cap
- GNL 1.7B
- HRMY 2.0B
- IPO Year
- GNL N/A
- HRMY 2020
- Fundamental
- Price
- GNL $7.76
- HRMY $34.50
- Analyst Decision
- GNL Buy
- HRMY Strong Buy
- Analyst Count
- GNL 4
- HRMY 8
- Target Price
- GNL $9.50
- HRMY $53.38
- AVG Volume (30 Days)
- GNL 1.5M
- HRMY 751.0K
- Earning Date
- GNL 05-07-2025
- HRMY 05-06-2025
- Dividend Yield
- GNL 13.08%
- HRMY N/A
- EPS Growth
- GNL N/A
- HRMY 13.13
- EPS
- GNL N/A
- HRMY 2.62
- Revenue
- GNL $789,545,000.00
- HRMY $744,852,000.00
- Revenue This Year
- GNL N/A
- HRMY $20.35
- Revenue Next Year
- GNL N/A
- HRMY $17.42
- P/E Ratio
- GNL N/A
- HRMY $13.16
- Revenue Growth
- GNL 38.85
- HRMY 20.62
- 52 Week Low
- GNL $6.51
- HRMY $26.47
- 52 Week High
- GNL $9.11
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- GNL 51.02
- HRMY 58.40
- Support Level
- GNL $7.48
- HRMY $33.47
- Resistance Level
- GNL $7.95
- HRMY $35.35
- Average True Range (ATR)
- GNL 0.15
- HRMY 1.13
- MACD
- GNL -0.01
- HRMY -0.10
- Stochastic Oscillator
- GNL 40.15
- HRMY 42.41
About GNL Global Net Lease Inc.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.